Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


QUOTED. 3 May 2019. Amy Culley.

Executive Summary

Biotronik started marketing its PK Papyrus balloon-expandable covered stent for treating acute perforations in the US after receiving a humanitarian device exemption from the US FDA last year. See what Biotronik's Amy Culley director of vascular intervention clinical studies said about the device here.

"Biotronik saw a need to develop and rethink how to design a product to have a single stent with a single cover. When you have an emergency situation, you want confidence in the ability to deliver the treatment quickly and effectively. –Amy Culley, director of vascular intervention clinical studies, Biotronik

Click here for a free trial of Medtech Insight


Related Content





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts